Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The glycine conjugation pathway is a mitochondrial, two-step enzymatic process responsible for the metabolism and detoxification of various endogenous and exogenous compounds. It plays a crucial role in converting potentially toxic substances into more water-soluble, less harmful products that can be excreted in urine. Key enzymes involved are ACSM2B (acyl-CoA synthetase) and GLYAT (glycine N-acyltransferase). Substrates like benzoate and salicylate are conjugated with glycine to form hippuric acid and salicyluric acid, respectively. The pathway maintains CoASH homeostasis, prevents accumulation of toxic organic acids, and influences mitochondrial ATP production. Variations in this pathway may impact susceptibility to liver cancer, musculoskeletal development issues, and metabolic disorders.
N/A
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycine Conjugation Pathway.